Cuál es el precio por CardieX Limited (CDX)

Precio por CardieX Limited (CDX) es de$0.01754999

Cuál es la capitalización de mercado por CardieX Limited (CDX)

Capitalización de mercado por CardieX Limited (CDX) es $2.52M

CardieX Limited (CDX) EPS

CardieX Limited, established in Sydney, Australia, in 1994, is a global innovator specializing in the design, production, and distribution of medical devices for cardiovascular health management. Operating across the Americas, Europe, and the Asia Pacific, the company collaborates with pharmaceutical firms by providing its advanced SphygmoCor XCEL devices. It also delivers comprehensive laboratory and data management services, ensuring high-quality datasets for clinical trial sponsors. Under its CONNEQT brand, CardieX develops cutting-edge home vascular health solutions, which encompass remote patient monitoring, tools for decentralized clinical trials, specialized wearables, and medical applications. A flagship product is the CONNEQT Pulse device, a home-based system that leverages proprietary SphygmoCor technology to precisely measure central blood pressure, arterial waveforms, and other vital arterial health parameters. CardieX serves a diverse clientele, including hospitals, clinics, research institutions, and pharmaceutical companies. The company also maintains a strategic alliance with LifeQ, Inc., focusing on wearable device technology. CardieX Limited was formerly known as AtCor Medical Holdings Limited until its name change in June 2018.

Año	EPS	Cambiar
Not enough data for the provided dates.

Año

EPS

Cambiar

Not enough data for the provided dates.

Empresa	EPS	Diferencia de EPS	País
Abbott Laboratories ABT.US	$3.11	-	US
Stryker Corporation SYK.US	$9.73	-	US
Medtronic plc MDT.US	$3.59	-	IE
Boston Scientific Corporation BSX.US	$2.48	-	US
Edwards Lifesciences Corporation EW.US	$1.74	-	US

Empresa

EPS

Diferencia de EPS

País